Table 1 Weighted* HLA allele group prevalence among children and mothers in the Uganda Sickle Cell Anemia KSHV Study, 2001-2002
Children | Women | ||||
|---|---|---|---|---|---|
HLA group | Number typed† | Percent positive for allele group (number positive) | Number typed† | Percent positive for allele group (number positive) | p-value ‡ |
HLA-A | 223 | 226 | |||
*01 | 5.1 (22) | 3.5 (22) | |||
*02 | 19.5 (82) | 20.0 (78) | |||
*03 | 5.2 (23) | 4.6 (28) | |||
*23 | 10.2 (42) | 8.8 (38) | |||
*29 | 5.0 (32) | 7.3 (37) | |||
*30 | 12.0 (75) | 13.7 (82) | |||
*36 | 5.4 (13) | 5.2 (13) | |||
*66 | 5.0 (26) | 8.0 (36) | |||
*68 | 11.5 (39) | 10.6 (43) | |||
*74 | 10.7 (38) | 6.2 (31) | |||
0.94 | |||||
HLA-B | 225 | 225 | |||
*07 | 4.9 (18) | 6.2 (18) | |||
*08 | 3.4 (18) | 3.1 (15) | |||
*15 | 10.5 (59) | 9.0 (65) | |||
*42 | 6.8 (35) | 8.9 (40) | |||
*44 | 3.9 (14) | 3.1 (16) | |||
*45 | 8.0 (32) | 11.9 (41) | |||
*49 | 1.5 (13) | 5.3 (16) | |||
*53 | 11.6 (40) | 8.7 (36) | |||
*57 | 5.9 (21) | 2.1 (22) | |||
*58 | 16.6 (59) | 16.8 (73) | |||
*82 | 6.1 (6) | 0.1 (2) | |||
0.98 | |||||
HLA-DRB1 | 223 | 227 | |||
*01 | 10.5 (48) | 8.0 (37) | |||
*03 | 9.4 (56) | 10.1 (59) | |||
*04 | 1.0 (4) | 1.7 (4) | |||
*07 | 6.5 (31) | 5.8 (37) | |||
*08 | 5.0 (20) | 5.6 (20) | |||
*11 | 28.2 (113) | 28.8 (116) | |||
*12 | 3.7 (11) | 6.1 (17) | |||
*13 | 11.7 (68) | 12.3 (59) | |||
*15 | 15.9 (61) | 14.4 (70) | |||
0.95 | |||||